14th March, 2023
Launch of Teicoplanin 200mg & 400mg IV Vials
Bowmed Ibisqus is pleased to announce the launch of our Teicoplanin IV Vials distributed in strengths of 200mg and 400mg.
Teicoplanin is a glycopeptide antibiotic with bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. Around 2 million doses of this product are administered in the UK each year and our launch will further reinforce the UK supply chain for this essential medicine.
The new products have been listed with AAH under codes TEI0008S (200mg) & TEI0007W (400mg). Stock is available for customers effective immediately.
If you would like to discuss a pricing arrangement or stock availability for Teicoplanin or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us